June 16, 2026 · Form 4 insider transaction
Kelsey Stephen Michael sold 4,175 shares of Revolution Medicines, Inc. at $156.12 per share, a transaction worth $651.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.; This transaction was executed in multiple trades at prices ranging from $156.1105 to $156.8250. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.; Includes 76,251 RSUs.; Includes 653 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026.